Sociedad Española de Farmacéuticos de Atención Primaria - SEFAP

What Sociedad Española de Farmacéuticos de Atención Primaria - SEFAP does

SEFAP (Sociedad Española de Farmacéuticos de Atención Primaria) is a non-profit professional society founded in 2008 and headquartered in Madrid that represents primary care pharmacists across Spain. The organization is staffed by 7 employees and operates from a single office at C/ Villanueva 11, 7º, 28001 Madrid. Its core mission is to promote the rational use of medicines and advance the role of pharmacists within Spain's primary healthcare system, serving as the convening professional body for pharmacists working in primary care settings.

SEFAP's product portfolio is content- and education-led rather than technology-led. It includes the Master's en Farmacia de Atención Primaria academic program, the recurring Perlas Farmacoterapéuticas training cycle, a 100-hour antimicrobial stewardship course (currently in its 5th edition, co-developed with PRAN and four major Spanish medical societies), and official positioning documents covering person-centered medication review, pharmaceutical care in socio-sanitary centers, the pharmacist service portfolio, and a European-leading biosimilar use analysis co-produced with BioSim. Distribution occurs through the dedicated eformación.sefap.es learning platform, an annual in-person congress, webinars, and an active social presence across X, Instagram, YouTube, Facebook, and WhatsApp.

The revenue model is recurring and member-funded: annual membership dues (cuotas) from individual primary care pharmacists form the core revenue stream, supplemented by reduced congress registration fees for members, training course fees (some free for members), and institutional grants from public bodies linked to the Spanish Ministry of Health. The society is not venture-backed, has no parent company, and is governed by its member-elected board. SEFAP does not operate proprietary technology infrastructure; its competitive position rests on brand authority, accredited educational content, and an institutional partnership network spanning physician societies and the national antimicrobial resistance plan.

Name

Sociedad Española de Farmacéuticos de Atención Primaria - SEFAP

Legal name

Sociedad Española de Farmacéuticos de Atención Primaria

Website

https://sefap.org

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

SEFAP is the Spanish Society of Primary Care Pharmacists, a non-profit professional association founded in 2008 and headquartered in Madrid that delivers continuing education, training courses, and official positioning documents to its primary care pharmacist members across Spain.

Ownership category

akta.pro rank

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership dues: SEFAP is funded primarily through annual membership fees (cuotas) from its pharmacist members, which fund the society's operations, publications, and educational activities.
2. Congress and course fees: Revenue generated from reduced fees for members registering for the annual congress and various training courses.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

SEFAP is a non-profit professional society that delivers continuing education, training, and knowledge products for primary care pharmacists in Spain. Its offering centers on a Master's program in Primary Care Pharmacy, the Perlas Farmacoterapéuticas webinar cycle, accredited courses such as the 100-hour antimicrobial use program, an annual congress, and authoritative positioning documents and research reports on rational medication use, biosimilars, and pharmaceutical care.

Product overview

SEFAP operates as a professional society rather than a technology company, offering educational programs, training courses, and official publications for primary care pharmacists. The portfolio includes a Master's program in Primary Care Pharmacy, the Perlas Farmacoterapéuticas training cycle with multiple sessions, the antimicrobial use course developed with PRAN, and official position documents including the medication review positioning, socio-sanitary center guidance, service portfolio, and European-leading biosimilar report. These offerings support the professional development and knowledge resources for pharmacists in primary care settings across Spain.

Differentiator

Problem solved

Functional benefit

Products and services

• Máster en Farmacia de Atención Primaria (Master's in Primary Care Pharmacy) Academic Master's degree program focused on primary care pharmacy practice, designed for pharmacists seeking to specialize in primary care pharmacy.
• Perlas Farmacoterapéuticas SEFAP Free educational webinar cycle for SEFAP members covering pharmacotherapy topics applicable to daily primary care pharmacy practice, with multiple sessions per year.
• Curso Uso Adecuado de Antimicrobianos en la Comunidad Accredited 100-hour course on appropriate antimicrobial use in the community, developed in collaboration with PRAN, SEMFYC, SEMERGEN, SEMG, and SEIMC; awards 11.9 continuing education credits.
• Biosimilares en Atención Primaria (Biosimilars in Primary Care report) First European analysis of biosimilar use in primary care, examining Spanish National Health System prescription consumption, regional strategies, and professional knowledge, with proposals and international experiences to improve implementation.
• Posicionamiento SEFAP en la revisión de la medicación centrada en la persona Official SEFAP position statement on person-centered medication review, addressing the role of primary care pharmacists in medication management.
• Posicionamiento SEFAP en la atención farmacéutica a centros sociosanitarios SEFAP position statement on pharmaceutical care in socio-sanitary centers, establishing guidelines for pharmacy services in those facilities.
• Cartera de Servicios del Farmacéutico de Atención Primaria Comprehensive service portfolio defining the role and responsibilities of primary care pharmacists in coordinated treatment management, supporting safe, effective, and efficient medication selection and use.
• Congreso SEFAP (Annual Congress) SEFAP's annual congress for primary care pharmacists in Spain, offering reduced registration fees for society members as a key networking and professional update event.

Quantifiable outcome

• First European analysis on biosimilar use in primary care
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and moderate.

• Plan Nacional frente a la Resistencia a los Antibióticos (PRAN)coreStrategic or Co-development Partner · 3 February 2025SEFAP collaborates with PRAN on the 'Uso Adecuado de Antimicrobianos en la Comunidad' course, a free 100-hour training program (5th edition) on appropriate antimicrobial use in the community. The partnership aims to combat antibiotic resistance through professional education.
• Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC)coreStrategic or Co-development Partner · 3 February 2025Collaborating organization in the development of the 'Uso Adecuado de Antimicrobianos en la Comunidad' course, contributing to multidisciplinary antimicrobial stewardship education.
• Sociedad Española de Médicos de Atención Primaria (SEMERGEN)coreStrategic or Co-development Partner · 3 February 2025Collaborating organization in the development of the 'Uso Adecuado de Antimicrobianos en la Comunidad' course, contributing to multidisciplinary antimicrobial stewardship education.
• Sociedad Española de Médicos Generales y de Familia (SEMG)coreStrategic or Co-development Partner · 3 February 2025Collaborating organization in the development of the 'Uso Adecuado de Antimicrobianos en la Comunidad' course, contributing to multidisciplinary antimicrobial stewardship education.
• Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC)coreStrategic or Co-development Partner · 3 February 2025Collaborating organization in the development of the 'Uso Adecuado de Antimicrobianos en la Comunidad' course, contributing infectious disease and clinical microbiology expertise.
• Comisión de Formación Continuada de Profesionales Sanitarios de la Comunidad de MadridmoderateStrategic or Co-development Partner · 1 January 2025Accrediting body for the antimicrobial use course, providing official continuing education credits (11.9 credits for first edition).
• BioSim (Sociedad Española de Biosimilares)coreStrategic or Co-development PartnerCollaboration on the 'Biosimilares en Atención Primaria' report, the first European analysis on biosimilar use in primary care settings. The report studies SNS prescription consumption, regional strategies, and professional knowledge.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC): Spanish Society of Family and Community Medicine — a sibling primary-care professional society that SEFAP actively partners with on antimicrobial stewardship courses. Operates a comparable model of continuing education, congresses, and position documents for primary-care physicians.
• Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC): Spanish Society of Infectious Diseases and Clinical Microbiology — partnered with SEFAP on the antimicrobial-use course. Operates the same professional-society model (dues-funded, education and congresses) but in the infectious-disease specialty rather than primary care.
• Sociedad Española de Médicos Generales y de Familia (SEMG): Third Spanish primary-care medical society collaborating with SEFAP on multidisciplinary antimicrobial training. Comparable professional-society model with continuing-education, congress, and position-document offerings for primary-care physicians.
• Sociedad Española de Biosimilares (BioSim): Biosim is SEFAP's co-author on the first European biosimilar-use analysis in primary care. Functions as a sector-specific industry association (biosimilar manufacturers and supporters), making it a direct peer in the Spanish health-professional-association space focused on a therapeutic topic.
• Sociedad Española de Médicos de Atención Primaria (SEMERGEN): Another Spanish primary-care medical society partnering with SEFAP on the antimicrobial-use course. Mirrors SEFAP's structure as a non-profit professional society delivering continuing education and consensus documents to primary-care clinicians.
• Sociedad Española de Farmacia Hospitalaria (SEFH): Spanish Society of Hospital Pharmacy — the closest direct peer, addressing the hospital-pharmacy rather than primary-care-pharmacy segment of the Spanish pharmacist profession. Operates as a non-profit professional society offering training, position documents, and congresses for its members, with the same membership-dues model as SEFAP.

Broad incumbents

• American Pharmacists Association (APhA): US national professional society for pharmacists — same membership-society, continuing-education, and advocacy model as SEFAP but serving a far larger US pharmacist workforce with a much broader scope (all sectors, not primary-care-specific).
• Royal Pharmaceutical Society (RPS): UK professional body for pharmacists — analogous model (membership society, continuing education, position statements, accreditation) but operating at national scale in a much larger pharmacy market. Comparable as a professional society governing pharmacist practice and education, though RPS is broader (all pharmacy sectors, not primary-care-specific).
• International Pharmaceutical Federation (FIP): Global pharmacy federation — comparable professional-body model with education, congresses, and policy positioning for pharmacists worldwide. Functions as a broader incumbent of which national societies like SEFAP are typically institutional members.
• Pharmaceutical Group of the European Union (PGEU): European umbrella body for community pharmacists — analogous professional-association model but at EU level, covering policy, education, and best-practice dissemination across member national pharmacy associations including Spanish ones.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Sefap_FAP
• YouTubeyoutube.com/@SEFAP_FAP
• Facebookfacebook.com/SociedadEspFarmaceuticosAtencionPrimariaSEFAP
• Instagraminstagram.com/sefap.fap
• LinkedInlinkedin.com/company/sociedad-espa%C3%B1ola-de-farmac%C3%A9uticos-de-atenci%C3%B3n-primaria-sefap

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sociedad Española de Farmacéuticos de Atención Primaria - SEFAP